Vardaki, I. Et Al. 2023. Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer. Prostate , vol.83, no.10 , 950-961.

Vardaki, I., Özcan, S., Fonseca, P., Lin, S., Logothetis, C. J., Yachnin, J., ... Ullen, A.(2023). Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer. Prostate , vol.83, no.10, 950-961.

Vardaki, Ioulia Et Al. "Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer," Prostate , vol.83, no.10, 950-961, 2023

Vardaki, Ioulia Et Al. "Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer." Prostate , vol.83, no.10, pp.950-961, 2023

Vardaki, I. Et Al. (2023) . "Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer." Prostate , vol.83, no.10, pp.950-961.

@article{article, author={Ioulia Vardaki Et Al. }, title={Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancer}, journal={Prostate}, year=2023, pages={950-961} }